imported>Ziv：(GR) Duplicate: File:1V-LSD Chemical Structure.svg → File:1V-LSD structure.svg Exact or scaled-down duplicate: c::File:1V-LSD structure.svg

2026-04-18T19:57:43Z

(GR) Duplicate: File:1V-LSD Chemical Structure.svg → File:1V-LSD structure.svg Exact or scaled-down duplicate: c::File:1V-LSD structure.svg

新页面

{{Drugbox
| IUPAC_name = (6a''R'',9''R'')-''N'',''N''-Diethyl-7-methyl-4-pentanoyl-4,,6,6a,7,8,9-hexahydroindolo[4,3-''fg'']quinoline-9-carboxamide
| image = 1V-LSD structure.svg

| tradename =
| legal_AU = S8
| legal_CA = Unscheduled
| legal_DE = NpSG
| legal_UK = PSA
| legal_US = Unscheduled (when wasn't sold for human consumption)
| legal_UN = Unscheduled
| legal_CN = 非药用类[[麻醉药品]]和[[精神药品]]管制品种
| routes_of_administration = oral

| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion = 
| CAS_number_Ref =
| CAS_number = 3028950-70-8
| ATC_prefix =
| ATC_suffix =
| PubChem = 162368540
| ChemSpiderID = None
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = V9TJ3HT283

| C = 25
| H = 33
| N = 3
| O = 2
| melting_point =
| smiles = CCN(CC)C(=O)[C@@H]5C=C2[C@@H](Cc3cn(C(=O)CCCC)c4cccc2c34)N(C)C5
| StdInChI = 1S/C25H33N3O2/c1-5-8-12-23(29)28-16-17-14-22-20(19-10-9-11-21(28)24(17)19)13-18(15-26(22)4)25(30)27(6-2)7-3/h9-11,13,16,18,22H,5-8,12,14-15H2,1-4H3/t18-,22-/m1/s1
| StdInChIKey = GIIBVGJWUZNECE-XMSQKQJNSA-N
| drug_name =
| alt =
| caption =
| type =
| MedlinePlus =
| licence_EU =
| licence_US =
| DrugBank =
}}

'''1V-LSD'''（学名：'''1-戊酰基-D-麦角酸二乙酰胺'''）是一种有机化合物，化学式为C25H33N3O2。它是一种[[精神药物]]及用于科研的[[迷幻药物]]。<ref>{{cite web |title=1V-LSD (solution) |url=https://www.caymanchem.com/product/35744/1v-lsd-(solution) |website=www.caymanchem.com |language=en}}</ref><ref>{{cite news |title=1V-LSD PsychonautWiki |url=https://psychonautwiki.org/wiki/1V-LSD |newspaper=Psychonautwiki |language=en}}</ref>它是天然[[麥角酸]]的人工合成的[[衍生物]]，是[[麥角酸二乙酰胺|LSD]]的[[结构类似物]]。<ref name = "Brandt_2021">{{cite journal | vauthors = Brandt SD, Kavanagh PV, Westphal F, Pulver B, Morton K, Stratford A, Dowling G, Halberstadt AL | display-authors = 6 | title = Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1-valeroyl-d-lysergic acid diethylamide (1V-LSD) | journal = Drug Testing and Analysis | pages = 733–740 | date = November 2021 | volume = 14 | issue = 4 | pmid = 34837347 | doi = 10.1002/dta.3205 | pmc = 9191648 }}</ref>它从2022年起被德国管制<ref>{{cite web |title=1V-LSD - legales LSD 3.0 | website=[[YouTube]] | date=10 September 2021 |url=https://www.youtube.com/watch?v=EN6n6pUb7bs |language=de}}</ref>，2024年7月1日起被[[中华人民共和国]]管制<ref>{{Cite web |last=National Medical Products Administration (NMPA) of China |date=2024-06-19 |title=关于将溴啡等46种物质列入《非药用类麻醉药品和精神药品管制品种增补目录》的公告 |url=https://www.nmpa.gov.cn/xxgk/ggtg/ypggtg/ypqtggtg/20240619150650124.html|access-date=2025-03-22}}</ref>。

[[File:1v-LSD strip blotters.jpg|thumb|1V-LSD的条形吸墨纸]]

== 参见 ==
* [[1B-LSD]]
* [[1cP-LSD]]
* [[1D-LSD]]
* [[1P-LSD]]
* [[AL-LAD]]
* [[LSD]]

== 参考文献 ==
{{Reflist}}

{{致幻剂}}

[[Category:策划药]]
[[Category:迷幻药物]]
[[Category:麦角酰胺]]
[[Category:前药]]
[[Category:血清素受体激动剂]]

1V-LSD - 版本历史

imported>Ziv：​(GR) Duplicate: File:1V-LSD Chemical Structure.svg → File:1V-LSD structure.svg Exact or scaled-down duplicate: c::File:1V-LSD structure.svg

imported>Ziv：(GR) Duplicate: File:1V-LSD Chemical Structure.svg → File:1V-LSD structure.svg Exact or scaled-down duplicate: c::File:1V-LSD structure.svg